Literature DB >> 31346954

Biological characterization of the UW402, UW473, ONS-76 and DAOY pediatric medulloblastoma cell lines.

Ricardo Bonfim-Silva1, Karina Bezerra Salomão2, Thais Valéria Costa de Andrade Pimentel3, Camila Cristina Branquinho de Oliveira Menezes4, Patrícia Vianna Bonini Palma4, Aparecida Maria Fontes2.   

Abstract

Medulloblastoma (MB) is the most common malignant brain tumor in children. Recent advances in molecular technologies allowed to classify MB in 4 major molecular subgroups: WNT, SHH, Group 3 and Group 4. In cancer research, cancer cell lines are important for examining and manipulating molecular and cellular process. However, it is important to know the characteristics of each cancer cell line prior to use, because there are some differences among them, even if they originate from the same cancer type. This study aimed to evaluate the similarities and differences among four human medulloblastoma cell lines, UW402, UW473, DAOY and ONS-76. The medulloblastoma cell lines were analyzed for (1) cell morphology, (2) immunophenotyping by flow cytometry for some specifics surface proteins, (3) expression level of adhesion molecules by RT-qPCR, (4) proliferative potential, (5) cell migration, and (6) in vivo tumorigenic potential. It was observed a relationship between cell growth and CDH1 (E-chaderin) adhesion molecule expression and all MB cell lines showed higher levels of CDH2 (N-chaderin) when compared to other adhesion molecule. ONS-76 showed higher gene expression of CDH5 (VE-chaderin) and higher percentage of CD144/VE-chaderin positive cells when compared to other MB cell lines. All MB cell lines showed low percentage of CD34, CD45, CD31, CD133 positive cells and high percentage of CD44, CD105, CD106 and CD29 positive cells. The DAOY cell line showed the highest migration potential, the ONS-76 cell line showed the highest proliferative potential and only DAOY and ONS-76 cell lines showed tumorigenic potential in vivo. MB cell lines showed functional and molecular differences among them, which it should be considered by the researchers in choosing the most suitable cellular model according to the study proposal.

Entities:  

Keywords:  In vivo tumorigenic potential; Medulloblastoma cell lines; Migration; Proliferation; Surface proteins

Year:  2019        PMID: 31346954      PMCID: PMC6787134          DOI: 10.1007/s10616-019-00332-3

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  51 in total

1.  Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.

Authors:  Songmei Geng; Yuanyuan Guo; Qianqian Wang; Lan Li; Jianli Wang
Journal:  Arch Dermatol Res       Date:  2012-06-28       Impact factor: 3.017

2.  Intertumoral Heterogeneity within Medulloblastoma Subgroups.

Authors:  Florence M G Cavalli; Marc Remke; Ladislav Rampasek; John Peacock; David J H Shih; Betty Luu; Livia Garzia; Jonathon Torchia; Carolina Nor; A Sorana Morrissy; Sameer Agnihotri; Yuan Yao Thompson; Claudia M Kuzan-Fischer; Hamza Farooq; Keren Isaev; Craig Daniels; Byung-Kyu Cho; Seung-Ki Kim; Kyu-Chang Wang; Ji Yeoun Lee; Wieslawa A Grajkowska; Marta Perek-Polnik; Alexandre Vasiljevic; Cecile Faure-Conter; Anne Jouvet; Caterina Giannini; Amulya A Nageswara Rao; Kay Ka Wai Li; Ho-Keung Ng; Charles G Eberhart; Ian F Pollack; Ronald L Hamilton; G Yancey Gillespie; James M Olson; Sarah Leary; William A Weiss; Boleslaw Lach; Lola B Chambless; Reid C Thompson; Michael K Cooper; Rajeev Vibhakar; Peter Hauser; Marie-Lise C van Veelen; Johan M Kros; Pim J French; Young Shin Ra; Toshihiro Kumabe; Enrique López-Aguilar; Karel Zitterbart; Jaroslav Sterba; Gaetano Finocchiaro; Maura Massimino; Erwin G Van Meir; Satoru Osuka; Tomoko Shofuda; Almos Klekner; Massimo Zollo; Jeffrey R Leonard; Joshua B Rubin; Nada Jabado; Steffen Albrecht; Jaume Mora; Timothy E Van Meter; Shin Jung; Andrew S Moore; Andrew R Hallahan; Jennifer A Chan; Daniela P C Tirapelli; Carlos G Carlotti; Maryam Fouladi; José Pimentel; Claudia C Faria; Ali G Saad; Luca Massimi; Linda M Liau; Helen Wheeler; Hideo Nakamura; Samer K Elbabaa; Mario Perezpeña-Diazconti; Fernando Chico Ponce de León; Shenandoah Robinson; Michal Zapotocky; Alvaro Lassaletta; Annie Huang; Cynthia E Hawkins; Uri Tabori; Eric Bouffet; Ute Bartels; Peter B Dirks; James T Rutka; Gary D Bader; Jüri Reimand; Anna Goldenberg; Vijay Ramaswamy; Michael D Taylor
Journal:  Cancer Cell       Date:  2017-06-12       Impact factor: 31.743

3.  Hand1 overexpression inhibits medulloblastoma metastasis.

Authors:  Swapna Asuthkar; Maheedhara R Guda; Sarah E Martin; Reuben Antony; Karen Fernandez; Julian Lin; Andrew J Tsung; Kiran K Velpula
Journal:  Biochem Biophys Res Commun       Date:  2016-06-11       Impact factor: 3.575

4.  CD34 expression by embryonic hematopoietic and endothelial cells does not require c-Myb.

Authors:  D S Krause; M L Mucenski; A M Lawler; W S May
Journal:  Exp Hematol       Date:  1998-10       Impact factor: 3.084

5.  Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.

Authors:  Yuh-Yu Chou; Yung-Ming Jeng; Tan-Tsao Lee; Fu-Chang Hu; Hsin-Lien Kao; Wei-Chou Lin; Po-Lin Lai; Rey-Heng Hu; Ray-Hwang Yuan
Journal:  Ann Surg Oncol       Date:  2007-08-07       Impact factor: 5.344

6.  Identification of a cancer stem cell in human brain tumors.

Authors:  Sheila K Singh; Ian D Clarke; Mizuhiko Terasaki; Victoria E Bonn; Cynthia Hawkins; Jeremy Squire; Peter B Dirks
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

7.  Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cells.

Authors:  X Cao; J Geradts; M W Dewhirst; H-W Lo
Journal:  Oncogene       Date:  2011-06-13       Impact factor: 9.867

8.  CD90 promotes cell migration, viability and sphere‑forming ability of hepatocellular carcinoma cells.

Authors:  Ketao Zhang; Siyao Che; Zheng Su; Shangyou Zheng; Huayao Zhang; Shanglin Yang; Wenda Li; Jianping Liu
Journal:  Int J Mol Med       Date:  2017-12-08       Impact factor: 4.101

9.  Soluble VE-cadherin in metastatic breast cancer: an independent prognostic factor for both progression-free survival and overall survival.

Authors:  Pauline Rochefort; Sylvie Chabaud; Jean-Yves Pierga; Olivier Tredan; Etienne Brain; François-Clément Bidard; Camille Schiffler; Helena Polena; Abir Khalil-Mgharbel; Isabelle Vilgrain; Thomas Bachelot
Journal:  Br J Cancer       Date:  2017-01-05       Impact factor: 7.640

10.  Cell surface profiling using high-throughput flow cytometry: a platform for biomarker discovery and analysis of cellular heterogeneity.

Authors:  Craig A Gedye; Ali Hussain; Joshua Paterson; Alannah Smrke; Harleen Saini; Danylo Sirskyj; Keira Pereira; Nazleen Lobo; Jocelyn Stewart; Christopher Go; Jenny Ho; Mauricio Medrano; Elzbieta Hyatt; Julie Yuan; Stevan Lauriault; Mona Meyer; Maria Kondratyev; Twan van den Beucken; Michael Jewett; Peter Dirks; Cynthia J Guidos; Jayne Danska; Jean Wang; Bradly Wouters; Benjamin Neel; Robert Rottapel; Laurie E Ailles
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

View more
  2 in total

1.  3D spheroid models of paediatric SHH medulloblastoma mimic tumour biology, drug response and metastatic dissemination.

Authors:  Sophie J Roper; Franziska Linke; Paul J Scotting; Beth Coyle
Journal:  Sci Rep       Date:  2021-02-19       Impact factor: 4.379

2.  Curcumin analogue BDDD-721 exhibits more potent anticancer effects than curcumin on medulloblastoma by targeting Shh/Gli1 signaling pathway.

Authors:  Weiyi Gong; Wenxuan Zhao; Gang Liu; Lei Shi; Xia Zhao
Journal:  Aging (Albany NY)       Date:  2022-07-06       Impact factor: 5.955

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.